Targeting synapse function and loss for treatment of neurodegenerative diseases

B Dejanovic, M Sheng, JE Hanson - Nature Reviews Drug Discovery, 2024 - nature.com
Synapse dysfunction and loss are hallmarks of neurodegenerative diseases that correlate
with cognitive decline. However, the mechanisms and therapeutic strategies to prevent or …

[HTML][HTML] The possible role of brain-derived neurotrophic factor in epilepsy

R AlRuwaili, HM Al-Kuraishy, AI Al-Gareeb… - Neurochemical …, 2024 - Springer
Epilepsy is a neurological disease characterized by repeated seizures. Despite of that the
brain-derived neurotrophic factor (BDNF) is implicated in the pathogenesis of …

Innate immune activation in neurodegenerative diseases

S Castro-Gomez, MT Heneka - Immunity, 2024 - cell.com
Activation of the innate immune system following pattern recognition receptor binding has
emerged as one of the major pathogenic mechanisms in neurodegenerative disease …

Microglia phagocytic mechanisms: Development informing disease

RM Beiter, PW Sheehan, DP Schafer - Current Opinion in Neurobiology, 2024 - Elsevier
Microglia are tissue-resident macrophages and professional phagocytes of the central
nervous system (CNS). In development, microglia-mediated phagocytosis is important for …

Microglial over-pruning of synapses during development in autism-associated SCN2A-deficient mice and human cerebral organoids

J Wu, J Zhang, X Chen, K Wettschurack, Z Que… - Molecular …, 2024 - nature.com
Autism spectrum disorder (ASD) is a major neurodevelopmental disorder affecting 1 in 36
children in the United States. While neurons have been the focus of understanding ASD, an …

[HTML][HTML] CSMD1 regulates brain complement activity and circuit development

ML Baum, DK Wilton, RG Fox, A Carey… - Brain, Behavior, and …, 2024 - Elsevier
Complement proteins facilitate synaptic elimination during neurodevelopmental pruning, but
neural complement regulation is not well understood. CUB and Sushi Multiple Domains 1 …

Immune Activation in Alzheimer Disease

A Mary, R Mancuso, MT Heneka - Annual Review of …, 2024 - annualreviews.org
Alzheimer disease (AD) is the most common neurodegenerative disease, and with no
efficient curative treatment available, its medical, social, and economic burdens are …

Astrocyte Regulation of Synapse Formation, Maturation, and Elimination

WS Chung, KT Baldwin… - Cold Spring Harbor …, 2024 - cshperspectives.cshlp.org
Astrocytes play an integral role in the development, maturation, and refinement of neuronal
circuits. Astrocytes secrete proteins and lipids that instruct the formation of new synapses …

[HTML][HTML] PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response

W Yue, X Li, X Zhan, L Wang, J Ma, M Bi, Q Wang… - Ebiomedicine, 2024 - thelancet.com
Background Poly (ADP-ribose) polymerase (PARP) inhibitors have emerged as promising
chemotherapeutic drugs primarily against BRCA1/2-associated tumours, known as synthetic …

[HTML][HTML] Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

J Sevigny, O Uspenskaya, LD Heckman, LC Wong… - Nature Medicine, 2024 - nature.com
GRN mutations cause progranulin haploinsufficiency, which eventually leads to
frontotemporal dementia (FTD-GRN). PR006 is an investigational gene therapy delivering …